Thetford Mines, Quebec – TheNewswire - March 10, 2022 – KDA Group Inc. (TSXV:KDA) (“KDA” or the “Corporation”) and its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”), are pleased to announce a partnership with Progitek Dev Inc. (“Progitek”) and their innovative dental software solutions called Dentitek (“Dentitek”), for the integration of its KRx electronic prescribing platform for dentists (the “KRx”).

“We are delighted to work with Progitek to commercialize the KRx. This partnership will allow Tech KDA’s KRx technology platform to be available, by our estimate, to nearly more than 80% of all dental clinics in the province of Quebec, including the previous partnership agreements we have signed,” said Marc Lemieux, Chief Executive Officer of KDA.

“With over 900 dental clinics benefiting from state-of-the-art features such as electronic medical records and comprehensive integrations with insurance companies, pharmacies and in-clinic dental equipment, Progitek has become the industry leader in dental management software in Quebec,” said Éric Vézina, President of Progitek.

“KRx software simplifies prescribing for dentists by putting essential information at their fingertips, so they can prescribe medications professionally, safely and efficiently,” added Marc Lemieux.

In Quebec, there are more than 5,000 dental professionals1 and over 20,000 dentists practice this profession in Canada2. The integration of both KRx and Dentitek systems will provide dentists with the clinical tools they need to optimize their time with their clients.

The KRx main features are:

• An intelligent e-prescriber integrated directly into dental software that dynamically analyzes the dentist's prescription profile and displays the appropriate medication. 

• Modules that electronically request the patient's drugs list from their pharmacist and electronically send their new prescriptions directly to their pharmacy. 

• Decision trees and algorithms for selected drugs as well as immediate information about the primary use of a drug taken by a patient in order to reduce medical risks to the patient. 

• Access to RxVigilance, a leader in Canadian drug database, to verify drug interactions and allergies, and automatically calculate the pediatric dosage when necessary. 

• Access to the Dossier Santé Québec (DSQ) for the patient’s medication history. 

ABOUT KDA GROUP

KDA Group is a leading technological innovations and specialized solutions provider in the pharmaceutical market. Today, it is a respected name for quality and expertise among the different stakeholders in the pharmaceutical and medical sector. Its management team is guided by a vision of continuing to lead the way in Quebec while extending operations across Canada and internationally. Additional information on the Corporation is available at www.kdagroup.ca and on SEDAR at www.sedar.com.

ABOUT PROGITEK DEV

Since 1995, Progitek provides innovative software solutions for various dental practice specialties. Their flagship product, Dentitek, is designed for dentists and allows practitioners to avoid relying on physical records. It also simplifies management while monitoring and optimizing productivity. Based in Quebec, the company serves all of Quebec, as well as Ontario and the Maritime provinces. Progitek has become the industry leader in the dental management software in Quebec. For more information, visit the company’s website at www.progitek.ca.

REFERENCES

1-Ordre des dentistes du Québec (odq.qc.ca)

2-Canadian Dental Association (cda-adc.ca)

- 30 -

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

This press release from KDA Group contains forward-looking statements. Forward-looking statements are typically identified by the words assumption, goal, guidance, objective, outlook, strategy, target, and other similar expressions, or future or conditional verbs such as aim, anticipate, believe, predict, could, expect, intend, may, plan, seek, should, strive, and will. By their nature, forward-looking statements require us to make estimates and assumptions and express opinions based on current conditions and anticipated developments, as well as other factors that Management may deem appropriate under the circumstances. There is inherent uncertainty and significant risk in these estimates, assumptions, and opinions, particularly of a commercial, economic, and competitive nature, and they are therefore subject to change. KDA Group cannot guarantee that these estimates, assumptions, and opinions will prove to be accurate.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

INFORMATION

Marc Lemieux

Chief Executive Officer

514 622-7370

info@groupekda.ca